Laboratorio Reig Jofre, S.A.

BME:RJF.D 株式レポート

時価総額:€217.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Laboratorio Reig Jofre 過去の業績

過去 基準チェック /16

Laboratorio Reig Jofre's earnings have been declining at an average annual rate of -7.8%, while the Pharmaceuticals industry saw earnings growing at 13.8% annually. Revenues have been growing at an average rate of 9.1% per year. Laboratorio Reig Jofre's return on equity is 2.7%, and it has net margins of 2.1%.

主要情報

-7.8%

収益成長率

-14.2%

EPS成長率

Pharmaceuticals 業界の成長5.0%
収益成長率9.1%
株主資本利益率2.7%
ネット・マージン2.1%
次回の業績アップデート26 Jul 2022

最近の業績更新

更新なし

Recent updates

更新なし

収支内訳

Laboratorio Reig Jofre の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

BME:RJF.D 収益、費用、利益 ( )EUR Millions
日付収益収益G+A経費研究開発費
31 Dec 212405740
30 Sep 212376770
30 Jun 212346760
31 Mar 212346760
31 Dec 202346760
30 Sep 202298750
30 Jun 202296720
31 Mar 202196700
31 Dec 192065680
30 Sep 191997680
30 Jun 191889670
31 Mar 191889660
31 Dec 181859650
30 Sep 1818510600
30 Jun 181799590
31 Mar 181759580
31 Dec 171729580
30 Sep 171645580
30 Jun 171647570
31 Mar 171648570
31 Dec 161618550
30 Sep 161605550
30 Jun 161595540
31 Mar 161565531
31 Dec 151579530

質の高い収益: RJF.D has high quality earnings.

利益率の向上: RJF.D's current net profit margins (2.1%) are lower than last year (2.4%).


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: RJF.D's earnings have declined by 7.8% per year over the past 5 years.

成長の加速: RJF.D's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

収益対業界: RJF.D had negative earnings growth (-10.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (8.9%).


株主資本利益率

高いROE: RJF.D's Return on Equity (2.7%) is considered low.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘